Medical Treatment of Cushing’s Syndrome
Endogenous Cushing’s syndrome (CS) refers to the manifestations of chronic cortisol excess. This rare disease is associated with multiple comorbidities, impaired quality of life, and increased mortality. The management of CS remains challenging. Regardless of the underlying cause, surgical resection...
Saved in:
| Main Authors: | Laurence Guignat, Jerome Bertherat |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Endocrine Society
2025-02-01
|
| Series: | Endocrinology and Metabolism |
| Subjects: | |
| Online Access: | http://e-enm.org/upload/pdf/enm-2024-501.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cushing's Disease in Children: Report of Three Cases
by: Ping-Yi Hsu, et al.
Published: (2010-10-01) -
Efficacy and Safety of Levoketoconazole in Managing Cushing’s Syndrome: A Systematic Review
by: Shinjan Patra, et al.
Published: (2024-08-01) -
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing’s syndrome
by: Yasutaka Tsujimoto, et al.
Published: (2024-12-01) -
High recovery rate of adrenal function after successful surgical treatment of Cushing’s syndrome
by: Annenienke C van de Ven, et al.
Published: (2025-04-01) -
Steroid Induced Cushing’s Syndrome in an Asthmatic patient: a Case Report
by: Sumol RATNA, et al.
Published: (2023-09-01)